Physician profile
Vladimir Pech
NPI 1639509490
$433.31
in general payments reported to CMS, 2019-2025
11 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $54.89 · 2021: $26.26 · 2022: $102 · 2023: $42.74 · 2024: $63.28 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $250.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $90.49 | 2025 | |
| Merck Sharp & Dohme LLC | $81.54 | 2020-2022 | |
| Pfizer INC. | $70.05 | 2024-2025 | |
| Glaxosmithkline, LLC. | $50.07 | 2022-2024 | Shingrix, Arexvy |
| Novo Nordisk INC | $39.84 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $26.65 | 2022 | |
| Dermira, INC. | $16.33 | 2020 | |
| Amgen INC. | $15.74 | 2025 | Repatha, Otezla |
| Vbi Vaccine (Delaware) INC. | $15.37 | 2022 | |
| Cranial Technologies, INC | $13.90 | 2022 | |
| Lilly USA, LLC | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladimir Pech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.